Nektar Therapeutics (NKTR) PT Raised to $89 at Mizuho Securities on NKTR-214 Potential
Tweet Send to a Friend
Mizuho Securities raised its price target on Nektar Therapeutics (NASDAQ: NKTR) to $89.00 (from $45.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
